OPEN END TURBO SHORT - COOPER COMPANIES Stock

Certificat

DE000MG2HFF6

Market Closed - Börse Stuttgart 15:57:38 2024-06-04 EDT
0.055 EUR -3.51% Intraday chart for OPEN END TURBO SHORT - COOPER COMPANIES
Current month+1.79%
1 month-34.48%
Date Price Change
24-06-04 0.055 -3.51%
24-06-03 0.057 +1.79%
24-05-31 0.056 -37.08%
24-05-30 0.089 +3.49%
24-05-29 0.086 +10.26%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 03:57 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG2HFF
ISINDE000MG2HFF6
Date issued 2024-04-17
Strike 100.1 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.106
Lowest since issue 0.015

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
94.56 USD
Average target price
108.2 USD
Spread / Average Target
+14.38%
Consensus